| scholarly article | Q13442814 |
| P2093 | author name string | Lofts FJ | |
| Evans TR | |||
| Knight MJ | |||
| Mansi JL | |||
| Dalgleish AG | |||
| Glees JP | |||
| P2860 | cites work | Reporting results of cancer treatment | Q29620070 |
| Carboplatin dosage: prospective evaluation of a simple formula based on renal function | Q33429552 | ||
| Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer | Q33466760 | ||
| A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). | Q33491452 | ||
| Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features | Q33493746 | ||
| The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma | Q34066231 | ||
| Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM). | Q34683749 | ||
| Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells | Q37408713 | ||
| Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma. | Q40718943 | ||
| 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group study | Q41117009 | ||
| Pancreatic cancer: the greatest oncological challenge | Q41941898 | ||
| A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study | Q44583571 | ||
| Chemotherapy prolongs survival in inoperable pancreatic carcinoma. | Q51133785 | ||
| Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial. | Q64915286 | ||
| Chemotherapy of gastrointestinal cancer | Q66838721 | ||
| Percutaneous insertion of Hickman-type catheters | Q67801818 | ||
| Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial | Q68495699 | ||
| Phase II study of epirubicin in advanced adenocarcinoma of the pancreas | Q69835594 | ||
| Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study | Q70229143 | ||
| Activity of cisplatin in adenocarcinoma of the pancreas | Q70534415 | ||
| Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen | Q72504253 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| cisplatin | Q412415 | ||
| fluorouracil | Q238512 | ||
| P304 | page(s) | 1260-1264 | |
| P577 | publication date | 1996-05-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer | |
| P478 | volume | 73 |
| Q36671589 | A phase II irinotecan–cisplatin combination in advanced pancreatic cancer |
| Q36644189 | A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer |
| Q36294910 | Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas? |
| Q73307098 | Bile duct stents: is there an increased rate of complications in patients receiving chemotherapy? |
| Q33541099 | Chemotherapy for advanced pancreatic cancer: it may no longer be ignored |
| Q46941754 | Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts |
| Q50930679 | Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma. |
| Q41823940 | Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro |
| Q33371777 | Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma |
| Q33412612 | Epirubicin, cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma |
| Q43846320 | Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site. |
| Q46963760 | Evaluation of the efficacy of combined continuous arterial infusion and systemic chemotherapy for the treatment of advanced pancreatic carcinoma |
| Q33369849 | Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas |
| Q51233307 | Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience. |
| Q33327923 | Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). |
| Q36914356 | Is it relevant that intra-arterial chemotherapy may be effective for advanced pancreatic cancer? |
| Q37960190 | Management of advanced pancreatic cancer |
| Q54976122 | Pancreaticoduodenectomy after downstaging of pancreatic carcinoma by chemotherapy. |
| Q74346099 | Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site |
| Q42032242 | Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer |
| Q73104089 | Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group |
| Q78023541 | Practical recommendations for the management of adenocarcinoma of the pancreas |
| Q34842592 | Subcutaneous chest ports via the internal jugular vein. A retrospective study of 117 oncology patients |
| Q34084253 | The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential |
| Q41774661 | Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospectiv |
| Q42635395 | Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy |
| Q73085269 | [Contribution of gemcitabine in the treatment of advanced pancreatic cancer] |
Search more.